Research »
FDA gives emergency authorization to COVID-19 drug

Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 and is being studied in clinical trials at University Hospital.

Read More
Patient Care »
Cancer prevention and screening during the COVID-19 pandemic

It’s important for the public to keep their cancer screenings, tests and treatments during this time. In this pre-recorded message, Ruben Mesa, M.D., FACP, explains that the Mays Cancer Center is open and safe for patients.

Watch Dr. Mesa's Message
Community »
Music that heals

Grace Notes community choir is virtually connecting people living with dementia and their families through the healing power of music.

Read More
Our Impact on COVID-19

Check out UT Health San Antonio's response in the battle against COVID-19 and the stories that inspire us.

Check out the Impact site
Say Thank You!

Leave a note of encouragement and support for all staff and providers at UT Health San Antonio.

Leave a note
How can you help in the fight against COVID-19?

Learn more about the UT Health San Antonio COVID-19 Response Fund.

Learn how to help
In the News »
Keeping you informed about the latest in research, patient care and academics at The University of Texas Health Science Center at San Antonio, now called UT Health San Antonio.
Produced by Marketing, Communications and Media.
Copyright © 2020 - UT Health Science Center at San Antonio, 7703 Floyd Curl Dr., Mail Code 8037, San Antonio, TX 78229. All rights reserved. Story ideas can be sent to